Initiatives in the Medical and Healthcare Fields
First written in FY2017-Q1. 17 of 30 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-08-13.
1 other company's latest entry also says "Restated".
- FY2026AdvancedAnnual report
「In addition, to establish expertise and enhance the value provided in the medical and healthcare sector, we established our consolidated subsidiary キーウェアメディカル株式会社 on 15 January this year and proceeded with preparations for its business launch on 1 April this year.」
In the medical and healthcare fields, the company progressed to establishing a specialized subsidiary and preparing to commence operations on 1 April 2026. - FY2026-H1AdvancedAnnual report
「In the medical solutions business, the company also strengthened its packaged solutions, including by renewing the clinical laboratory testing system Medlas-Fit.」
The company strengthened its packaged solutions in the medical solutions business and renewed the Medlas-Fit clinical laboratory testing system. - FY2025RestatedAnnual report
「In addition, to strengthen the medical solutions business, the company consolidated the business within group subsidiaries into the company, established a delivery structure leveraging the group's comprehensive capabilities, and significantly enhanced the functionality of its flagship pathology testing system, Medlas-BR, before launching the enhanced version.」
The annual report also confirms the consolidation of the medical solutions business into the company and the enhancement and launch of Medlas-BR. - FY2025-H1AdvancedAnnual report
「In addition, to strengthen the medical solutions business, the company consolidated the business within the group subsidiaries into the company in April this year. In that business, the company is focusing on strengthening product competitiveness and promoting sales activities, including through the launch of Medlas-BR, its flagship pathology testing system and a proprietary software package for medical institutions, after significantly enhancing its functionality.」
Following the consolidation of the medical solutions business, the company has proceeded with enhancing Medlas-BR, launching its enhanced version, and pursuing sales activities. - FY2024AdvancedAnnual report
「In addition, to strengthen the medical solutions business, the company consolidated the group's businesses effective 1 April and established a structure to provide stronger support for resolving customer issues, while significantly enhancing the functionality of Medlas-BR, its flagship pathology testing system and a proprietary software package for medical institutions.」
The company consolidated its medical solutions business and significantly enhanced the functionality of its flagship pathology testing system. - FY2024-Q3AdvancedAnnual report
「In addition, the company proceeded with plans to strengthen the structure of its medical solutions business and decided to consolidate within the company, from April this year, the medical solutions businesses dispersed among group subsidiaries.」
Regarding the medical solutions business, the company decided to consolidate within the company from April 2024 the business dispersed among group subsidiaries. - FY2022-Q2RestatedAnnual report
「In its new businesses, the company will continue to develop operations in agricultural ICT and healthcare, as well as」
The company continues to identify healthcare as a priority area for its new businesses. - FY2021RestatedAnnual report
「With a view to creating and developing new businesses, the company is pursuing agricultural ICT, healthcare, and the DX First Step Solution,」
The company continues to identify healthcare as one of the priority areas for its new businesses. - FY2021-Q1AdvancedAnnual report
「This increased from the previous fiscal year, owing to the acquisition of new government and medical-sector projects.」
The acquisition of new medical-sector projects is cited as a factor behind the increase in order intake in the systems development business. - FY2020RestatedAnnual report
「In its new businesses, the company will continue its initiatives in agricultural ICT and the medical and healthcare fields, as well as」
The company continues its initiatives in the medical and healthcare fields as part of its new businesses. - FY2020-Q3RestatedAnnual report
「In its new businesses, the company will continue its initiatives in agricultural ICT and the medical and healthcare fields, as well as」
The company continues its initiatives in the medical and healthcare fields as part of its new businesses. - FY2020-Q2RestatedAnnual report
「In its new businesses, the company will continue its initiatives in agricultural ICT and the medical and healthcare fields, as well as」
The company continues to identify the medical and healthcare fields as priority areas for its new businesses. - FY2020-Q1RestatedAnnual report
「In its new businesses, the company will continue its initiatives in agricultural ICT and the medical and healthcare fields, as well as」
The company continues its initiatives in the medical and healthcare fields as part of its new businesses. - FY2019RestatedAnnual report
「The company will work to create and develop new businesses, focusing on agricultural ICT, healthcare, and the VSC productivity improvement consulting service.」
The company continues to identify the medical and healthcare fields as priority areas for its new businesses. - FY2018AdvancedAnnual report
「As a result, order intake and net sales increased substantially from the previous fiscal year, owing to the acquisition of major transportation and telecommunications projects and the expansion of government, medical, and financial-sector projects.」
The company made progress in acquiring projects, including the expansion of medical-sector projects, and order intake and net sales in the systems development business increased from the previous fiscal year. - FY2018-Q3AdvancedAnnual report
「Order intake and net sales increased substantially year on year, owing to the acquisition of a major transportation-sector project in the first quarter and projects in the medical, telecommunications, and transportation sectors in the third quarter.」
The company made progress in acquiring projects, including medical-sector projects, and order intake and net sales in the systems development business increased year on year. - FY2018-Q2AdvancedAnnual report
「Order intake and net sales increased substantially from the same period of the previous year, owing to continued strong performance in the support services business following the first quarter, as well as the commissioning of a demonstration project for next-generation medicine as part of a new business.」
A specific development is cited in the medical and healthcare fields: the company was commissioned to conduct a demonstration project for next-generation medicine. - FY2018-Q1RestatedAnnual report
「In new businesses, we promoted operations including agricultural ICT, the medical and healthcare sectors, and the VSC productivity improvement consulting service, working to diversify our earnings base.」
The company continues its initiatives in the medical and healthcare fields as part of its new businesses. - FY2017-Q2RestatedAnnual report
「The company will continue its initiatives in agricultural ICT and the medical and healthcare fields, as well as」
The company reiterates its continuing initiatives in the medical and healthcare fields. - FY2017-Q1First statedAnnual report
「We continue to work in agricultural ICT and the medical and healthcare sectors」
Medical and healthcare are cited as continuing new areas for portfolio diversification.